Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 18
2004 12
2005 12
2006 13
2007 16
2008 16
2009 22
2010 26
2011 22
2012 22
2013 19
2014 23
2015 17
2016 15
2017 12
2018 20
2019 13
2020 13
2021 11
2022 10
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Results by year

Filters applied: . Clear all
Page 1
Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only.
Hugosson J, Månsson M, Wallström J, Axcrona U, Carlsson SV, Egevad L, Geterud K, Khatami A, Kohestani K, Pihl CG, Socratous A, Stranne J, Godtman RA, Hellström M; GÖTEBORG-2 Trial Investigators. Hugosson J, et al. N Engl J Med. 2022 Dec 8;387(23):2126-2137. doi: 10.1056/NEJMoa2209454. N Engl J Med. 2022. PMID: 36477032 Free PMC article. Clinical Trial.
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer.
Hugosson J, Roobol MJ, Månsson M, Tammela TLJ, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Carlsson SV, Talala KM, Lilja H, Denis LJ, Recker F, Paez A, Puliti D, Villers A, Rebillard X, Kilpeläinen TP, Stenman UH, Godtman RA, Stinesen Kollberg K, Moss SM, Kujala P, Taari K, Huber A, van der Kwast T, Heijnsdijk EA, Bangma C, De Koning HJ, Schröder FH, Auvinen A; ERSPC investigators. Hugosson J, et al. Among authors: lilja h. Eur Urol. 2019 Jul;76(1):43-51. doi: 10.1016/j.eururo.2019.02.009. Epub 2019 Feb 26. Eur Urol. 2019. PMID: 30824296 Free PMC article. Clinical Trial.
Screening and prostate-cancer mortality in a randomized European study.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. Among authors: lilja h. N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18. N Engl J Med. 2009. PMID: 19297566 Free article. Clinical Trial.
Genetically adjusted PSA levels for prostate cancer screening.
Kachuri L, Hoffmann TJ, Jiang Y, Berndt SI, Shelley JP, Schaffer KR, Machiela MJ, Freedman ND, Huang WY, Li SA, Easterlin R, Goodman PJ, Till C, Thompson I, Lilja H, Van Den Eeden SK, Chanock SJ, Haiman CA, Conti DV, Klein RJ, Mosley JD, Graff RE, Witte JS. Kachuri L, et al. Among authors: lilja h. Nat Med. 2023 Jun;29(6):1412-1423. doi: 10.1038/s41591-023-02277-9. Epub 2023 Jun 1. Nat Med. 2023. PMID: 37264206 Free PMC article.
Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139-46.
Vickers A, Nordström T, Assel M, Lilja H, Grönberg H, Eklund M. Vickers A, et al. Among authors: lilja h. Eur Urol. 2018 Aug;74(2):e35-e36. doi: 10.1016/j.eururo.2018.04.027. Epub 2018 May 3. Eur Urol. 2018. PMID: 29731258 Free PMC article. No abstract available.
Reply by Authors.
Stuopelyte K, Sabaliauskaite R, Bakavicius A, Haflidadóttir BS, Visakorpi T, Väänänen RM, Patel C, Danila DC, Lilja H, Lazutka JR, Ulys A, Jankevicius F, Jarmalaite S. Stuopelyte K, et al. Among authors: lilja h. J Urol. 2020 Jul;204(1):77-78. doi: 10.1097/JU.0000000000000803.02. Epub 2020 Apr 28. J Urol. 2020. PMID: 32343215 No abstract available.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators. Schröder FH, et al. Among authors: lilja h. Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6. Lancet. 2014. PMID: 25108889 Free PMC article. Clinical Trial.
Reply by Authors.
Vertosick EA, Häggström C, Sjoberg DD, Hallmans G, Johansson R, Vickers AJ, Stattin P, Lilja H. Vertosick EA, et al. Among authors: lilja h. J Urol. 2020 Aug;204(2):287-288. doi: 10.1097/JU.0000000000001007.02. Epub 2020 May 20. J Urol. 2020. PMID: 32432507 No abstract available.
Author Reply.
Vickers AJ, Eastham JA, Scardino PT, Lilja H. Vickers AJ, et al. Among authors: lilja h. Urology. 2016 May;91:17-8. doi: 10.1016/j.urology.2015.12.069. Epub 2016 Mar 15. Urology. 2016. PMID: 26992811 No abstract available.
Perspective on Prostate Cancer Screening.
Carlsson SV, Lilja H. Carlsson SV, et al. Among authors: lilja h. Clin Chem. 2019 Jan;65(1):24-27. doi: 10.1373/clinchem.2018.293514. Epub 2018 Nov 20. Clin Chem. 2019. PMID: 30459166 Free PMC article. No abstract available.
302 results